371 related articles for article (PubMed ID: 33918836)
1. Phage-Displayed Peptides for Targeting Tyrosine Kinase Membrane Receptors in Cancer Therapy.
Aloisio A; Nisticò N; Mimmi S; Maisano D; Vecchio E; Fiume G; Iaccino E; Quinto I
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918836
[TBL] [Abstract][Full Text] [Related]
2. Phage display screening of therapeutic peptide for cancer targeting and therapy.
Saw PE; Song EW
Protein Cell; 2019 Nov; 10(11):787-807. PubMed ID: 31140150
[TBL] [Abstract][Full Text] [Related]
3. Eph receptors as cancer targets for antibody-based therapy.
Tang FHF; Davis D; Arap W; Pasqualini R; Staquicini FI
Adv Cancer Res; 2020; 147():303-317. PubMed ID: 32593404
[TBL] [Abstract][Full Text] [Related]
4. Targeting the Eph System with Peptides and Peptide Conjugates.
Riedl SJ; Pasquale EB
Curr Drug Targets; 2015; 16(10):1031-47. PubMed ID: 26212263
[TBL] [Abstract][Full Text] [Related]
5. Phage displayed peptides/antibodies recognizing growth factors and their tyrosine kinase receptors as tools for anti-cancer therapeutics.
Ronca R; Benzoni P; De Luca A; Crescini E; Dell'Era P
Int J Mol Sci; 2012; 13(4):5254-5277. PubMed ID: 22606042
[TBL] [Abstract][Full Text] [Related]
6. Identification of a RON tyrosine kinase receptor binding peptide using phage display technique and computational modeling of its binding mode.
Zarei O; Benvenuti S; Ustun-Alkan F; Hamzeh-Mivehroud M; Dastmalchi S
J Mol Model; 2017 Aug; 23(9):267. PubMed ID: 28823053
[TBL] [Abstract][Full Text] [Related]
7. Cancer-specific ligands identified from screening of peptide-display libraries.
Mori T
Curr Pharm Des; 2004; 10(19):2335-43. PubMed ID: 15279612
[TBL] [Abstract][Full Text] [Related]
8. Phage display biopanning and isolation of target-unrelated peptides: in search of nonspecific binders hidden in a combinatorial library.
Bakhshinejad B; Zade HM; Shekarabi HS; Neman S
Amino Acids; 2016 Dec; 48(12):2699-2716. PubMed ID: 27650972
[TBL] [Abstract][Full Text] [Related]
9. Targeting Receptor Tyrosine Kinases Using Monoclonal Antibodies: The Most Specific Tools for Targeted-Based Cancer Therapy.
Shabani M; Hojjat-Farsangi M
Curr Drug Targets; 2016; 17(14):1687-1703. PubMed ID: 26424402
[TBL] [Abstract][Full Text] [Related]
10. Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells.
Dmitrieva MD; Voitova AA; Dymova MA; Richter VA; Kuligina EV
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396774
[TBL] [Abstract][Full Text] [Related]
11. Peptide phage display as a tool for drug discovery: targeting membrane receptors.
Molek P; Strukelj B; Bratkovic T
Molecules; 2011 Jan; 16(1):857-87. PubMed ID: 21258295
[TBL] [Abstract][Full Text] [Related]
12. Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors.
Montor WR; Salas AROSE; Melo FHM
Mol Cancer; 2018 Feb; 17(1):55. PubMed ID: 29455659
[TBL] [Abstract][Full Text] [Related]
13. Using phage as a platform to select cancer cell-targeting peptides.
Li X; Mao C
Methods Mol Biol; 2014; 1108():57-68. PubMed ID: 24243240
[TBL] [Abstract][Full Text] [Related]
14. Identification of natural ligands for SH2 domains from a phage display cDNA library.
Cochrane D; Webster C; Masih G; McCafferty J
J Mol Biol; 2000 Mar; 297(1):89-97. PubMed ID: 10704309
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7.
Pero SC; Oligino L; Daly RJ; Soden AL; Liu C; Roller PP; Li P; Krag DN
J Biol Chem; 2002 Apr; 277(14):11918-26. PubMed ID: 11809769
[TBL] [Abstract][Full Text] [Related]
16. Targeting Axl and Mer kinases in cancer.
Verma A; Warner SL; Vankayalapati H; Bearss DJ; Sharma S
Mol Cancer Ther; 2011 Oct; 10(10):1763-73. PubMed ID: 21933973
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase receptors as attractive targets of cancer therapy.
Bennasroune A; Gardin A; Aunis D; Crémel G; Hubert P
Crit Rev Oncol Hematol; 2004 Apr; 50(1):23-38. PubMed ID: 15094157
[TBL] [Abstract][Full Text] [Related]
18. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment.
Hailing T; Yonghong P; Yufeng Z; Haitao T
J Control Release; 2022 Sep; 349():592-605. PubMed ID: 35872181
[TBL] [Abstract][Full Text] [Related]
19. Discovery and Characterization of a High-Affinity Small Peptide Ligand, H1, Targeting FGFR2IIIc for Skin Wound Healing.
Zhao Y; Wang Q; Jin Y; Li Y; Nie C; Huang P; Li Z; Zhang B; Su Z; Hong A; Chen X
Cell Physiol Biochem; 2018; 49(3):1033-1048. PubMed ID: 30196288
[TBL] [Abstract][Full Text] [Related]
20. Phage display screening identifies a novel peptide to suppress ovarian cancer cells in vitro and in vivo in mouse models.
Zhou C; Kang J; Wang X; Wei W; Jiang W
BMC Cancer; 2015 Nov; 15():889. PubMed ID: 26555399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
